All PRODUCTS

期刊論文Journal articles

楊雯雯、吳慧敏、劉嘉玲、鄭國本、余明隆、蒲若芳、盧勝男、簡榮南（2023）。C型肝炎病毒抗體快篩試劑的運用。台灣公共衛生雜誌，42(6)，594-611。
Wen-Wen Yang, Yi-Chen Juan, Grace Hui-Min Wu, Raoh-Fang Pwu. The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments. Drug Saf (2023). https://doi.org/10.1007/s40264-023-01386-1
Rong-Nan Chien, Sheng-Nan Lu, Grace Hui-Min Wu, Wen-Wen Yang, Raoh-Fang Pwu, Chia-Ling Liu, Kuo-Pen Cheng, Shih-Chung Chen, Chien-Jen Chen, Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan, The Journal of Infectious Diseases, Volume 228, Issue Supplement_3, 15 September 2023, Pages S180–S188, https://doi.org/10.1093/infdis/jiad016
Chien-Chin Chen, Chyong-Huey Lai, Chih-Long Chang, Wen-Fang Cheng, Raoh-Fang Pwu, Jane Tsai, Peng-Hui Wang, Jacqueline Whang-Peng, Gi-Ming Lai, Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives, Journal of the Formosan Medical Association, 2023, (in press) https://doi.org/10.1016/j.jfma.2023.06.018.
楊雯雯、劉嘉玲、吳慧敏、鄭國本、盧勝男、簡榮南、蒲若芳. 推動消除C肝政策之回顧. 台灣衛誌；2023:42(2):165-179.
KC S, Lin LW, Bayani DBS, Zemlyanska Y, Adler A, Ahn J, Chan K, Choiphel D, Genuino-Marfori AJ, Kearney B, Liu Y, Nakamura R, Pearce F, Prinja S, Pwu RF, Shafie AA, Sui B, Suwantika A, Tunis S, Wu H, Zalcberg J, Zhao K, Isaranuwatchai W, Teerawattananon Y, & Wee H. (2023). What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection into the Past and A Way Forward. International Journal of Health Policy and Management, 12(1), 1-9. doi: 10.34172/ijhpm.2023.6858
Shiroiwa T, Murata T, Ahn J, Li X, Nakamura R, Teerawattananon Y, Kun Z, Shafie AA, Valverde H, Lam H, Ng K, Nadjib M, Pwu RF, Nugraha RR, Chen YC & Fukuda T. (2022). Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia. Value in health regional issues, 32, 62–69. https://doi.org/10.1016/j.vhri.2022.07.002
楊雯雯、吳慧敏、盧勝男、劉嘉玲、鄭國本、蒲若芳. 滾動調整2025年C肝消除治療目標數. 台灣衛誌；2022:41(6):567-71.
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Value Health. 2022; 25: 3-9.
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. Value Health. 2022; 25: 10-31.
Lu CY, Tang CH, Fu T, Pwu RF, Ho YF. Pneumococcal conjugate vaccines in Taiwan: Optimizing health gains in children and older adults through constrained optimization modeling: Pneumococcal conjugate vaccines optimization in Taiwan. Int J Infect Dis. 2021. Nov 5;S1201-9712(21)00851-1.  doi: 10.1016/j.ijid.2021.10.058. Online ahead of print.
Chien RN, Lu SN, Pwu RF, Wu GH, Yang WW, Liu CL. Taiwan accelerates its efforts to eliminate hepatitis C. Glob Health Med. Released July 05, 2021. Online ISSN 2434-9194. Doi:https://doi.org/10.35772/ghm.2021.01064.
Wu GHM, Yang WW, Liu CL, Pwu RF, Chien RN, Lee PC, Chen SC, Chen DS, Lu SN. The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study. J Formos Med Assoc. 2021; 120: 1444-51.
Lou J, KC S, Toh K, Dabak S, Adler A, Ahn J, Bayani D, Chan K, Choiphel D, Chua B, Genuino AJ, Guerrero AM, Kearney B, Lin LW, Liu Y, Nakamura R, Pearce F, Prinja S, Pwu RF, Shafie AA, Sui B, Suwantika A, Teerawattananon Y, Tunis S, Wu HM, Zalberg J, Zhao K, Isaranuwatchai W, Wee HL. Real-world data for health technology assessment for reimbursement decisions in Asia: Current landscape and a way forward. International Journal of Technology Assessment in Health Care. 2020, 1-7. doi:10.1017/S0266462320000628
Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, Jia J, Tian Q, Aggarwal R, Muljono DH, Omata M, Ooka Y, Han KH, Lee HW, Jafri W, Butt AS, Chong CH, Lim SG, Pwu RF, Chen DS. (2020). Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. The lancet. Gastroenterology & hepatology, 5(2), 167–228. https://doi.org/10.1016/S2468-1253(19)30342-5
劉嘉玲、楊雯雯、吳慧敏、鄭國本、蒲若芳.  臺灣 C 型肝炎消除的國家政策與軌跡. 愛之關懷. 2019;109:6-16.
Teerawattananon Y, Rattanavipapong W, Lin L, Dabak S, Gibbons B, Isaranuwatchai W, Toh K, Cher B, Pierce F, Bayani D, Nakamura R, Pwu R, Shafie A, Adhikari D, Prinja S, Babidge, W. Landscape analysis of health technology assessment (HTA): Systems and practices in Asia. International Journal of Technology Assessment in Health Care, 2019;35(6):416-421. doi:10.1017/S0266462319000667
從英國發展早期感知與預警系統的經驗為例，看台灣健康照護體系之應用. 楊雯雯、蒲若芳. 台灣衛誌 2019；38(3)：236-251. 
Teerawattananon Y, Luz K, Yothasmutra C, Pwu RF, Ahn J, Shafie AA, Chalkidou K, Tantivess S, Santatiwongchai B, Rattanavipapong W, Dabak S. HISTORICAL DEVELOPMENT OF THE HTAsiaLINK NETWORK AND ITS KEY DETERMINANTS OF SUCCESS. International Journal of Technology Assessment in Health Care, 2018;34(3), 260-266. doi:10.1017/S0266462318000223
Shantakumar S, Pwu RF, D’Silva L, Wurst K, Kuo YW, Yang YY, Juan YC, Chan KA. Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study. BMC Pulm Med. 2018;18(1):16
Wu GH, Pwu RF, Chen SC. Achieving hepatitis C elimination in Taiwan-Overcoming barriers by setting feasible strategies. J Formos Med Assoc, 117 (2018), pp. 1044-1045
Hailey D, Werko S, Rosen M, Macpherson K, Myles S, Gallegos Rivero V, Hipolito-Olivares C, Sihvo S, Pwu RF, Yang WW, Chen YC, Perez Galan A, Aleman A, Villamil E. Influence of Health Technology Assessment and Its Measurement. Int J Technol Assess Health Care 2016;32(6): 376-384.
Chiu WT, Pwu RF, Gau CS. Affordable health technology assessment in Taiwan: A model for middle-income countries. J Formos Med Assoc. 2015;114(6):481-3.
Soon SS, Lopes G, Lim HY, Wong-Rieger D, Bahri S, Hickinbotham L, Jha A, Ko BS, MacDonell D, Pwu RF, Shih R, Sirachainan E, Suh DC, Wale J, Zhang X, Wee HL. A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region. Orphanet J Rare Dis. 2014; 9: 137.
Tan EC, Pwu RF, Chen DR, Yang MC. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan? Qual Life Res. 2014;23(2):687-96.
Hailey D, Werko S, Bakri R, Cameron A, Gohlen B, Myles S, Pwu RF, Yothasamut J. Involvement of consumers in health technology assessment activities by Inahta agencies. Int J Technol Assess Health Care. 2013;29(1): 79-83.
Aljunid SM, Srithamrongsawat S, Chen W, Bae SJ, Pwu RF, Ikeda S, et al. Health-Care Data Collecting, Sharing, and Using in Thailand, China Mainland, South Korea, Taiwan, Japan, and Malaysia. Value in health. 2012;15(1):S132-S8.
Chow IH, Tang CH, You SL, Liao CH, Chu TY, Chen CJ, Chen CA, Pwu RF. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system. Br J Cancer 2010;103:1773-82.
Pwu RF, Liu CY, Ko SY, Tsai IC, Yang YK. Pharmacoeconomic evaluation of paliperidone extended release versus olanzapine or quetiapine in the treatment for patients with schizophrenia in Taiwan. Taiwanese Journal of Psychiatry [Taipei] 2010; 24: 281-91.
Liao CH, Liu JT, Pwu RF, You SL, Chow I, Tang CH. Valuation of the economic benefits of human papilomavirus vaccine in Taiwan. Value in Health, 2009, 12(S3), S74-77.
Tang CH, Pwu RF, Tsai IC, Wang HI, You SL, Chen CA, Scuffham PA, Hsieh CY, Chou CY, Lin SR, Chen YD, Chen CJ. Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system. Arch Gynecol Obstet 2009.
Dasbach EJ, Insinga RP, Yang YC, Pwu RF, Lac C, Elbasha, EH. The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan. Asian Pacific J Cancer Prev 2008; 9 (3): 459-566.
Lacey L, Chien RN, Chuang WL, Pwu RF. Economic evaluation of chronic hepatitis B treatments in Taiwan. J Gastroenterol Hepatol. Apr 2008;23(4):571-579.
Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Internal Medicine Journal 2005; 35 (3):188-190.
Wang SJ, Fuh JL, Juang KD, Lu SR, Hsu LC, Chen WT, Pwu RF. Evolution of migraine diagnosis in adolescents: a 3-year annual survey. Cephalalgia 2005; 25(5):333-8.
Hsu HC, Pwu RF. Too Late to Quit? Effect of Smoking and Smoking Cessation on Morbidity and Mortality Among the Elderly in a Longitudinal Study. The Kaohsiung Journal of Medical Sciences 2004; 20(10):484-91.
Fuh JL, Pwu RF, Wang SJ, Chen YH. Measuring Alzheimer’s Disease Progression with Transition Probabilities in the Taiwanese Population. International journal of geriatric psychiatry 2004; 19(3):266-70.
Pwu RF, Chan KA.  Cost-effectiveness analysis of interferon-alpha therapy in the treatment of chronic hepatitis B in Taiwan.  J Formos Med Assoc 2002;101:632-41.
Chen CJ, You SL, Pwu RF, Wang LY, Lin YP, Hsi GC, Hsi MS, Ho HC, Lee CT, Lin CG and et al. Community-based cervical cancer screening in seven townships in Taiwan. Journal of the Formosan Medical Association 1995;94 :S103-11


專書/專書篇章Book Chapter(s)


蒲若芳、楊雯雯、吳慧敏。追求分配正義建立臺灣NICE。載於黃煌雄、江東亮（主編）， 第三波健保改革之路（頁137-164）。台北市：遠見天下文化
湯澡薰、吳慧敏、蒲若芳。健康經濟與經濟評估。載於吳肖琪、鄭守夏(編輯)，衛生行政與管理。台北市：財團法人陳拱北醫學基金會

技術報告及其他Technical Reports and Others


陳冠如、洪瑜黛、楊雯雯、洪春旬、伍雪苹編輯（2023）。罕見疾病創新治療及藥物給付政策建言書（計畫總主持人：蔡輔仁；共同主持人：曾敏傑、蒲若芳、楊銘欽）。財團法人罕見疾病基金會。https://www.tfrd.org.tw/tfrd/assets/uploads/library_b1/66/tfrd_20231109142545.pdf
Besley, S., Cole, A., Pwu, R., Hsieh, C., 2023. Real-World Evidence: Current Best Practice for Reimbursement Decision-making. OHE Contract Research Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/real-world-evidence-current-bestpractice/


國際參與Projects participating




ISPOR Health Economic Publication Guidelines Good Reporting Practices Task Force (CHEERS) 2022.
Development of new preference-based measure (PBM) for Asia, initiated by Center for Outcomes Research and Economic Evaluation for Health (C2H) and National Institute of Public Health (NIPH), Japan. Since 2019.
RWE for HTA in Asia Working Group, initiated by Saw Swee Hock School of Public Health and HITAP. (since 2019)
APAC Liver Disease Alliance.
HTA for All initiative.

Journal Articles

1.Oze I, Ito H, Koyanagi YN, et al. Obesity is associated with biliary tract cancer mortality and incidence: A pooled analysis of 21 cohort studies in the Asia Cohort Consortium. Int J Cancer. 2023. doi: 10.1002/ijc.34794. (IF=6.4, 49/318, Q1)
2.Yang JJ, Wen W, Zahed H, et al. Lung Cancer Risk Prediction Models for Asian Ever-Smokers. J Thorac Oncol. 2023. doi: 10.1016/j.jtho.2023.11.002. (IF=20.4, 13/241, Q1)
3.Chang YH, Hsu WL, Lee YK, et al. Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study. Cancer Med. 2023;12:15350-15357. doi: 10.1002/cam4.6084. (IF=4.0, 96/241, Q2) 陳詠宸,許婉倫老師為共同作者.
4.Tsai YS, Chen YC, Chen TI, et al. Incidence trends of oral cavity, oropharyngeal, hypopharyngeal and laryngeal cancers among males in Taiwan, 1980-2019: a population-based cancer registry study..BMC Cancer. 2023;23:213. doi: 10.1186/s12885-023-10651-6. (IF=3.8, 109/241, Q2) 陳詠宸,許婉倫老師為共同作者
5.Rich T, Chrisinger BW, Kaimal R, et al. Contemplative Practices Behavior Is Positively Associated with Well-Being in Three Global Multi-Regional Stanford WELL for Life Cohorts.Int J Environ Res Public Health. 2022;19:13485. doi: 10.3390/ijerph192013485. (IF=3.2, 146/275, Q3)
 6.Hsu CH, Lin YJ, Chen YC, et al. Human Papillomavirus and Risk of Colorectal Cancer: An Analysis of Nationwide Claims Data. Medicina (Kaunas). 2022; 58:1461. doi: 10.3390/medicina58101461. (IF=0.1, 296/327, Q4)
7.Lee S, Jang J, Abe SK, et al. Association between body mass index and oesophageal cancer mortality: a pooled analysis of prospective cohort studies with >800 000 individuals in the Asia Cohort Consortium. Int J Epidemiol. 2022;51:1190-1203. doi: 10.1093/ije/dyac023. (IF=4.7, 58/207, Q2)
8.Lin CR, Lee YK, Chiang CJ, et al. Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study.World J Gastroenterol. 2022;28:3695-3705. doi: 10.3748/wjg.v28.i28.3695. (IF=4.3, 42/139, Q2) 陳詠宸老師為共同作者
9.Chiang CJ, Jhuang JR, Yang YW, et al. Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan. .JAMA Netw Open. 2022;5:e2222367. doi: 10.1001/jamanetworkopen.2022.22367. (IF=13.8, 15/169, Q1)
10.Leung CY, Huang HL, Abe SK, et al. Association of Marital Status With Total and Cause-Specific Mortality in Asia. JAMA Netw Open. 2022;5:e2214181. doi: 10.1001/jamanetworkopen.2022.14181. (IF=13.8, 15/169, Q1)
11.NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet1, doi: 10.1016/S0140-6736(21)01330-1. (IF=168.9, 1/169, Q1)

Project
 



PROJECT
FROM AND TO
 Implementation Status
PI
Performance


HPV-attributed Oropharyngeal Cancer in Taiwan:A National Cancer
Registry Database Research Approach
112.01.01-113.07.31
執行中
游山林
Post x 1
Manuscript x 1


Nationwide population-based study of surgical quality of roboti
 with endometrial cancer
112.12.01-113.07.31
執行中
游山林
Post x 1




 

Journal Articles

【Published】

Chang CM, Chen YC, Wu WT, Lin TK, Chou YC, Lin MH, Sun CA. Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study. Osteoporosis international; 34(7): 1223-1230. (非第一或通訊作者，SCI，IF=4.0, ENDOCRINOLOGY & METABOLISM: 62/145)
Chang YH, Hsu WL, Lee YK, Chiang CJ, Yang YW, You SL, Chen YC*, Lai TS. Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study. Cancer medicine 2023; 12(14): 15350-15357.（共同通訊作者，SCI，IF=4.0, ONCOLOGY: 92/241）
Chen TI, Lee FJ, Hsu WL, Chen YC*, Chen M. Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection. Cancers 2023; 15(4). （共同通訊作者，SCI，IF=5.2, ONCOLOGY: 72/241）
Chi HW, Cho HC, Yang AY, Chen YC, Chen JW. Effects of Different Voice Rest on Vocal Function After Microlaryngeal Surgery: A Systematic Review and Meta-Analysis. The Laryngoscope 2023; 133(1): 154-161. (非第一或通訊作者，SCI，IF=2.6, MEDICINE, RESEARCH & EXPERIMENTAL: 56/189)
Lin MH, Wu WT, Chen YC, Lin TK, Chou YC, Sun CA. Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study. Diabetology & metabolic syndrome 2023; 15(1): 96. (非第一或通訊作者，SCI，IF=4.8, ENDOCRINOLOGY & METABOLISM: 40/145)
Lin MH, Wu WT, Chen YC, Lu CH, Su SC, Kuo FC, Chou YC, Sun CA. Association between Non-Steroidal Anti-Inflammatory Drugs Use and the Risk of Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study. Journal of clinical medicine 2022; 11(11). (非第一或通訊作者，SCI，IF=3.9, MEDICINE, GENERAL & INTERNAL: 58/167)
Liu HS, Chen CD, Lee CC, Chen YC*, Cheng WF. Age Specific Risks of Uterine Cancer in Type 2 Diabetes and Associated Comorbidities in Taiwan. Cancers 2022; 14(19). （共同通訊作者，SCI，IF=5.2, ONCOLOGY: 72/241）
Shiroiwa T, Murata T, Ahn J, Li X, Nakamura R, Teerawattananon Y, Kun Z, Shafie AA, Valverde H, Lam H, Ng K, Nadjib M, Pwu RF, Nugraha RR, Chen YC, Fukuda T. Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia. Value in health regional issues 2022; 32: 62-69. (非第一或通訊作者，ESCI，IF=2.0 , HEALTH POLICY & SERVICES)
Sung YF, Tsai CT, Kuo CY, Lee JT, Chou CH, Chen YC, Chou YC, Sun CA. Use of Hormone Replacement Therapy and Risk of Dementia: A Nationwide Cohort Study. Neurology 2022. (非第一或通訊作者，SCI，IF=9.9, CLINICAL NEUROLOGY: 12/212)
Tsai MC, Chou YC, Lee YK, Hsu WL, Tang CS, Chen SY, Huang SP, Chen YC*, Lee JM. Secular Trends in Incidence of Esophageal Cancer in Taiwan from 1985 to 2019: An Age-Period-Cohort Analysis. Cancers 2022; 14(23). （通訊作者，SCI，IF=5.2, ONCOLOGY: 72/241）
Tsai YS, Chen YC, Chen TI, Lee YK, Chiang CJ, You SL, Hsu WL, Liao LJ. Incidence trends of oral cavity, oropharyngeal, hypopharyngeal and laryngeal cancers among males in Taiwan, 1980-2019: a population-based cancer registry study. BMC cancer 2023; 23(1): 213. (非第一或通訊作者，SCI，IF=3.8, ONCOLOGY: 109/241)
Yang RY, Yang AY, Chen YC, Lee SD, Lee SH, Chen JW. Association between Dysphagia and Frailty in Older Adults: A Systematic Review and Meta-Analysis. Nutrients 2022; 14(9)（共同第一作者，SCI，IF=5.9, NUTRITION & DIETETICS: 17/88）


【Reviewer Invited】


Tsai SA, Lu CY, TI Chen, Huang SP, Chen YC*, Adverse Events from HPV Vaccination: A Nationwide Survey in Taiwan (VACCINE submitted)
Wu JY, Shyu YK, Lee YK, Wang UC, Chiang CJ, You SL, Liao LJ, Hsu WL, Chen YC. Fertility Dynamics and Female Thyroid Cancer Incidence: Insights from Taiwan's Fluctuating Fertility Rates following a Baby Boom.


Project
【Executing】


輔大新光計畫 112-SKH-FJU-07

綜合心血管疾病危險因子作為過早死亡風險預測模型之研究

國民健康署：HPV疫苗接種服務專案管理計畫(112-113年)

Journal Articles

Chung CS, Wu CY, Lin YH, Lo WC Cheng PC, Hsu WL, Liao LJ. Screening and Surveillance of Esophageal Cancer by Magnifying Endoscopy with Narrow Band Imaging Improves the Survival of Hypopharyngeal Cancer Patients. Front Oncol (accepted) (非第一或通訊作者，SCI，IF=4.7, Oncology: 85/241)
Lou PJ, Lam WKJ, Hsu WL, Pfeiffer RM, Yu KJ, Chan MLC, Lee CTV, Chen TC, Terng SD, Tsou YA, Leu YS, Liao LJ, Chang YL, Chien YC, Wang CP, Lin CY, Hua CH, Lee JC, Yang TL, Hsiao CH, Wu MS, Tsai MH, Cheng HC, Hildesheim A, Chen CJ, Chan KCA, and Liu Z for the GEV-NPC group. Performance and Operational Feasibility of EBV-based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches. J Clin Oncol. 2023 Sep 10;41(26):4257-4266 (非第一或通訊作者，SCI，IF=45.4, Oncology: 7/241)
Chang YH, Hsu WL, Lee YK, Chiang CJ, Yang YW, You SL, Chen YC, Lai TS. Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study. Cancer Med. 2023 Jul;12(14):15350-15357. (非第一或通訊作者，SCI，IF=4.0, Oncology: 96/241)
Liao LJ, Hsu WL, Chen CJ, Chiu YL. Feature Reviews of the Molecular Mechanisms of Nasopharyngeal Carcinoma. Biomedicines. 2023 May 25;11(6):1528. (非第一或通訊作者，SCI，IF=4.7, Medicine, Research & Experimental: 54/136)
Schieber J, Pring M, Ness A, Liu Z, Hsu WL, Brenner N, Butt J, Waterboer T, Simon J. Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients. Cancers (Basel). 2023;15(9):2578. (非第一或通訊作者，SCI，IF=5.2, oncology: 72/241)
Argirion I, Pfeiffer RM, Proietti C, Coghill AE, Yu KJ, Middeldorp JM, Sarathkumara YD, Hsu WL, Chien YC, Lou PJ, Wang CP, Rothman N, Lan Q, Chen CJ, Mbulaiteye SM, Jarrett RF, Glimelius I, Smedby KE, Hjalgrim H, Hildesheim A, Doolan DL, Liu Z. Comparative analysis of the humoral immune response to the EBV proteome across EBV-related malignancies. Cancer Epidemiol Biomarkers Prev. 2023:EPI-22-0452  (非第一或通訊作者，SCI IF=4.090, Public, Environmental & Occupational Health: 60/245)
Lam WKJ, King AD, Miller JA, Liu Z, Yu KJ, Chua MLK, Ma BBY, Chen MY, Pinsky BA, Lou PJ, Woo JKS, Hsu WL, Simon J, Doolan DL, Waterboer T, Hui EP, Li H, Tsang RK, Wong KCW, Goh JP, Vlantis AC, Ai QY, Wong LM, Abdullah V, Lin JC, Chen CJ, Pfeiffer RM, Le QT, Lee AWM, Ji M, Cao S, Ma J, Chan ATC, Chan KCA, Hildesheim A. Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions. J Natl Cancer Inst. 2023 Apr 11;115(4):355-364. (非第一或通訊作者，SCI，IF=11.816，oncology: 28/241)
Tsai YS, Chen YC, Chen TI, Lee YK, Chiang CJ, You SL, Hsu WL, Liao LJ. Incidence trends of oral cavity, oropharyngeal, hypopharyngeal and laryngeal cancers among males in Taiwan, 1980-2019: a population-based cancer registry study. BMC Cancer. 2023 Mar 6;23(1):213. (共同通訊作者，SCI, IF=4.638，oncology: 109/245)
Chen TI, Lee FJ, Hsu WL, Chen YC, Chen M. Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection. Cancers (Basel). 2023;15(4):1148. (非第一或通訊作者，IF=5.2, oncology: 72/241)
Liao LJ, Tung YH, Lin YH, Hsu WL. Application of Real-time Submental Ultrasonography to Assess Swallowing. J Med Ultrasound. 2023 Mar 24;31(4):287-292. (非第一或通訊作者，IF=1.1, Radiology, Nuclear Medicine & Medical Imaging: 170/203)
Lo WC, Cheng PC, Hsu WL, Cheng PW, Liao LJ. A Novel Prediction Model Based on Quantitative Texture Analysis of Sonographic Images for Malignant Major Salivary Glandular Tumors. J Med Ultrasound. 2023 Jan 24;31(3):218-222. (非第一或通訊作者，IF=1.1, Radiology, Nuclear Medicine & Medical Imaging: 170/203)


Project
 



Project
Subsidy Institution
From and To
Status
PI
Result 


比較血液透析與腹膜透析病患心臟血管結構與血管鈣化指標的差異並找尋預測透析病患的心血管事件與死亡危險因子
輔大新光
112.01.01-113.03.31
執行中
徐婉倫、吳重寬
投稿中


透析中低血壓與瓣膜鈣化為透析病患的心血管事件與死亡的風險因子
輔大新光
113.01.01-113.12.31
執行中
徐婉倫、吳重寬
無


台灣口咽癌趨勢：全國資料研究
輔大亞東
112.08.01-113.07.31
執行中
徐婉倫、廖立人
無
 




 

期刊論文Journal articles

楊雯雯、吳慧敏、劉嘉玲、鄭國本、余明隆、蒲若芳、盧勝男、簡榮南（2023）。C型肝炎病毒抗體快篩試劑的運用。台灣公共衛生雜誌，42(6)，594-611。
Wen-Wen Yang, Yi-Chen Juan, Grace Hui-Min Wu, Raoh-Fang Pwu. The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments. Drug Saf (2023). https://doi.org/10.1007/s40264-023-01386-1



Rong-Nan Chien, Sheng-Nan Lu, Grace Hui-Min Wu, Wen-Wen Yang, Raoh-Fang Pwu, Chia-Ling Liu, Kuo-Pen Cheng, Shih-Chung Chen, Chien-Jen Chen, Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan, The Journal of Infectious Diseases, Volume 228, Issue Supplement_3, 15 September 2023, Pages S180–S188, https://doi.org/10.1093/infdis/jiad016
楊雯雯、劉嘉玲、吳慧敏、鄭國本、盧勝男、簡榮南、蒲若芳（2023）。推動消除C肝政策之回顧。台灣公共衛生雜誌，42(2)，165-179。https://doi.org/10.6288/TJPH.202304_42(2).112006
楊雯雯、吳慧敏、盧勝男、劉嘉玲、鄭國本、蒲若芳（2022）。滾動調整2025年C肝消除治療目標數。台灣公共衛生雜誌，41(6)，567-571。https://doi.org/10.6288/TJPH.202212_41(6).PF06
吳慧敏、楊雯雯、劉嘉玲、鄭國本、陳時中、陳建仁、蒲若芳（2021）。台灣2025年C肝消除的策略與進度。台灣公共衛生雜誌，40(1)，1-4。https://doi.org/10.6288/TJPH.202102_40(1).PF01
Grace Hui-Min Wu, Wen-Wen Yang, Chia-Ling Liu, Raoh-Fang Pwu, Rong-Nan Chien, Po-Chang Lee, Shih-Chung Chen, Ding-Shinn Chen, Sheng-Nan Lu. The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study. Journal of the Formosan Medical Association 2021 Jul;120(7):1444-1451. doi: 10.1016/j.jfma.2021.01.005. Epub 2021 Jan 27. PMID: 33516585.
Rong-Nan Chien, Sheng-Nan Lu, Raoh-Fang Pwu, Grace Hui-Min Wu, Wen-Wen Yang, Chia-Ling Liu. Taiwan accelerates its efforts to eliminate hepatitis C. Global Health & Medicine 2021 Oct 31;3(5):293-300. doi: 10.35772/ghm.2021.01064. PMID: 34782872; PMCID: PMC8562095.
劉嘉玲、楊雯雯、吳慧敏、鄭國本、蒲若芳（2019）。台灣C型肝炎消除的國家政策與軌跡。愛之關懷季刊，109，6-16。
楊雯雯、蒲若芳（2019）。從英國發展早期感知與預警系統的經驗為例，看台灣健康照護體系之應用。台灣公共衛生雜誌，38 (3), 236-251。https://doi.org/10.6288/TJPH.201906_38(3).107135
David Hailey, Sophie Werkö, Måns Rosén, Karen Macpherson, Susan Myles, Verónica Gallegos Rivero, Cecilia Hipólito-Olivares, Sinikka Sihvo, Jasmine Pwu, Wen-Wen Yang, Yong-Chen Chen, Ana Perez Galán, Alicia Aleman and Elena Villamil. (2016). Influence of Health Technology Assessment and Its Measurement. International Journal of Technology Assessment in Health Care, 32(6), 376–384. PMID: 28124969. (SCI)
楊雯雯（2010）。問一個可回答的問題。護理雜誌，57(6)，89-96。PMID: 21140349 (other)



專書/專書篇章Book Chapter(s)


蒲若芳、楊雯雯、吳慧敏。追求分配正義建立臺灣NICE。載於黃煌雄、江東亮（主編）， 第三波健保改革之路（頁137-164），2020年。台北市：遠見天下文化。ISBN：9789864799398
楊雯雯。護理資訊應用的倫理與法規。載於李亭亭、劉建財、李作英、楊雯雯、林怡君、許巧玲、涂明香、賴才雅、叢培瓏、張明利、侯宜菁、洪麗娟（作者），護理資訊、2020年。台北市：華杏出版股份有限公司。ISBN: 9789861945644


技術報告及其他Technical Reports and Others


陳冠如、洪瑜黛、楊雯雯、洪春旬、伍雪苹編輯（2023）。罕見疾病創新治療及藥物給付政策建言書（計畫總主持人：蔡輔仁；共同主持人：曾敏傑、蒲若芳、楊銘欽）。財團法人罕見疾病基金會。https://www.tfrd.org.tw/tfrd/assets/uploads/library_b1/66/tfrd_20231109142545.pdf
楊雯雯（2019）。再談早期感知與預警系統. 社團法人台灣藥物經濟暨效果研究學會會訊 3。https://www.taspor.org.tw/epaper_02.php?id=42.
國家消除C肝政策綱領編輯團隊（蒲若芳、吳慧敏、楊雯雯、劉嘉玲）（2019）。國家消除C肝政策綱領2018-2025。衛生福利部。ISBN／ISSN：9789860590562
Pei-Chun Chiang, Wen-Wen Yang. (2016). The Expenditure and Reimbursement of Orphan Drug in Taiwan: Challenges and Opportunities. ISPOR 21st Annual International Meeting, Washington DC, USA. (poster, PSY82; Value in Health, Volume 19, Issue 3, Page A287)
Wen-Wen Yang, Shiuan-Ru Chen, Yu-Chiao Wang, Raoh-Fang Pwu. (2015). Comparative effectiveness of tyrosine kinase inhibitors for chronic myeloid leukemia. The 4th HTAsiaLink Annual Conference, Taipei, Taiwan. (oral presentation: Best Podium Presentation in Health System Research)
楊雯雯（2015）。第一類新藥健保給付建議案相對療效執行方法與經驗分享。當代醫藥法規月刊。51，11-17。(other)
Wen-Wen Yang, Po-Ching Lo, Yu-Chiao Wang, and Raoh-Fang Pwu. (2014). Clinical effectiveness and cost-effectiveness of the current reimbursed stents for lower extremity arterial disease in Taiwan. The 3rd ISEHC (International Society of Evidence-Based Healthcare) Conference. Taipei, Taiwan. (poster, PSJ-099)
Wen-Wen Yang, Po-Ching Lo, Yu-Chiao Wang, Raoh-Fang Pwu. (2014). Clinical effectiveness and cost-effectiveness of the current reimbursed stents for lower extremity arterial disease in Taiwan. The 3th HTAsiaLink Annual Conference, Beijing, China. (oral presentation: Best Presentation Award in Economic Evaluations)
楊雯雯、陳詠宸、吳慧敏（2013）。醫療科技評估系統性文獻回顧執行方法建議。當代醫藥法規月刊。32，1-21。(other)
楊雯雯、蒲若芳（2013）。國際執行風險分攤機制的經驗。當代醫藥法規月刊。29, 1-20。(other)
Wen-Wen Yang, Yu-chiao Wang, Raoh-Fang Pwu. (2012). The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in Taiwan. ISPOR 5th Asia-pacific Conference, Taipei, Taiwan. (poster, PHP30)
Yu-Ting Kung, Wen-Yi Shau, Wen-Wen Yang, Jung-Chun Wang. (2012). Submission of New Drug Reimbursement and Pricing Applications to National Health Insurance (NHI) of Taiwan, Meeting Outcomes of the Drug Benefit Committee. ISPOR 5th Asia-pacific Conference, Taipei, Taiwan. (poster, PHP74)
楊雯雯、蒲若芳（2012）。罕見疾病用藥在澳洲醫療體系的收載現況。當代醫藥法規月刊，19，6-21。(other)
楊雯雯（2011）。第三屆亞洲華夏藥物經濟學及衛生科技評估論壇紀實（下）。當代醫藥法規月刊，9，8-38。(other)
楊雯雯（2011）。第三屆亞洲華夏藥物經濟學及衛生科技評估論壇紀實（上）。當代醫藥法規月刊，8，19-27。(other)
楊雯雯（2011）。國際風險分攤計畫實行現況 當代醫藥法規月刊，6，1-9。(other)
Yen-Chen Chen, Wen-Wen Yang, Hung-Wen Chiu. Artificial Neural Network Prediction for Cancer Survival Time by Gene Expression Data. Proceedings of the 3rd International Conference on Bioinformatics and Biomedical Engineering, Beijing, China, 11-13 June, iCBBE 2009:1-4.(EI)
Ruey-Ling Yeh, Ching Liu, Ben-Chang Shia, I-Jen Chiang, Wen-Wen Yang, Ginni Hsiang-Chun Tsai: Semantic Based Real-Time Clustering for PubMed Literatures. Proceedings of the 10th International Conference on Discovery Science, DS 2007, LNSC, 4755: 291-295, Springer Press.(EI)
Wen-Wen Yang, I-Jen Chiang, Ruey-Ling Yeh, and Hsiang-Chun Tsai, Combinatorial Topology-based Semantic Clustering Applied to PubMed, Proceedings of IEEE International Conference on Innovative Computing, Information and Control, Kumamoto, Japan, September, 5-7, 2007.(EI)